Mumbai sees more than 100 COVID cases: Is a new pandemic just around the corner?
Tired of too many ads? go ad free now
But is this new rise in numbers a sign of something bigger? Or is it just a passing ripple in the larger health landscape?
Here is all we need to know about what's happening, what it means, and whether this moment calls for fear, caution, or just a gentle reminder to stay aware.
A sharp rise in Mumbai: Should this be a wake-up call?
In May alone, Mumbai recorded 95 COVID-19 cases: a significant jump considering only 106 cases were reported in Maharashtra since January. Sixteen people are currently hospitalised.
While this number may not sound alarming compared to previous waves, it marks a clear shift in the virus's quiet behaviour over the past year.
Health workers have been moved from one hospital to another to prevent potential transmission, and tests are being conducted on people showing symptoms of influenza-like illness. This isn't just a random uptick — it's a cluster. And clusters, as history has shown, often precede waves.
(Pic courtesy: iStock)
What's happening beyond Mumbai?
Chennai is seeing a rise too. Doctors there are reporting a shift — fevers that were earlier assumed to be the flu are now turning out to be COVID-19. In fact, some surgeries like heart procedures and organ transplants have been postponed as a preventive measure.
Meanwhile, Gujarat, Karnataka, and even Puducherry have started reporting small but noticeable spikes. In Ahmedabad, seven new cases were detected in just one day — a sharp jump from its usual count of just one case a month.
Tired of too many ads? go ad free now
Even cities with no active cases, like Pune, are in alert mode. Fifty hospital beds have been set aside. That says something: not panic, but readiness.
While the current COVID-19 cases in India appear to be linked to the JN1 variant of Omicron, which has been circulating for some time, we must remain vigilant. Although hospitalizations haven't risen here yet, trends in countries like Singapore remind us not to be complacent. All age groups could be affected, with extremes of age and those with comorbidities at higher risk. It is crucial for authorities to step up surveillance and for hospitals to resume testing for COVID-19 in respiratory tract infections. Individuals must follow hand hygiene and respiratory etiquette. At present, there are no specific booster guidelines from Indian authorities, and we await further directives from ICMR. While most waves tend to pass without severe outcomes, we must stay cautious, monitor trends, and be prepared for any unexpected developments.
Dr. Sushila Kataria, Senior Director, Internal Medicine, Medanta, Gurugram
It's important to separate the numbers from the narratives. Yes, cases are increasing. But no, this isn't 2020 all over again.
The World Health Organization declared the global COVID-19 emergency over in May 2023. Since then, the virus has become endemic — meaning it still exists, but behaves more like the flu, with seasonal flare-ups.
Covid-19: Simple way of making a mask at home
What's happening now may not be the start of a new pandemic, but rather a localised surge, influenced by seasonal changes, immunity dips, or new variants. And while the word 'new variant' might stir up fear, most of these strains remain mild — especially in people who are vaccinated.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
ASHA workers to hold three-day dharna in Bengaluru; demands include better pay and job security
ASHA (Accredited Social Health Activist) workers from BBMP, Bangalore urban and rural districts, will launch a three-day dharna at Freedom Park on Seshadri road, starting August 12, as part of a State-wide agitation demanding better wages and job security. Organised under the umbrella of various ASHA workers' unions, the protest aims to draw the attention of the Karnataka Chief Minister and Health Department to what workers call long-standing neglect of their contributions, especially in the post-pandemic era. Among their primary demands, the ASHA workers are seeking a monthly compensation of ₹10,000, effective from April 2025. This includes both the State-provided honorarium and the Central government's incentive portion. Workers argue that despite being the frontline force in delivering rural healthcare and playing a crucial role during COVID-19, their efforts remain under-recognised and underpaid. The unions have also urged the State government to increase the ₹1,000 honorarium currently provided to all ASHA workers, in line with hikes recently granted to other scheme-based workers in the State Budget. Another key demand is job security. ASHA workers are strongly opposing any move to remove them under the guise of 'rationalisation,' fearing mass displacement and loss of livelihood. Meanwhile, the government has directed the officials to take necessary steps to ensure that public health services are not disrupted. The government issued a circular on Monday instructing the officials of Health and Family Welfare department to convince the ASHA workers of the facilities provided and to persuade them to not participate in the 'illegal agitation'. 'Information about ASHA workers who were absent from duty in their district limits every day from August 12 to 14, 2025, should be submitted to the Commissionerate. Apart from medical emergency, all types of leave should be restricted of all officers and staff of the Health Department (permanent/contract). And, the details of the activities of the ASHA workers who participated in the dharna should be entered on the website,' stated the circular.
News18
2 hours ago
- News18
Ousted FDA vaccine chief Vinay Prasad returning to agency
Washington, Aug 11 (AP) A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of biotech executives, patient groups and conservative allies of President Donald Trump. Dr Vinay Prasad is resuming leadership of the FDA centre that regulates vaccines and biotech therapies, a spokesperson for the Department of Health and Human Services said in a statement Monday. Prasad left the agency late last month after drawing ire of right-wing activists, including Laura Loomer, because of his past statements criticizing Trump. A longtime a critic of FDA's standards for approving medicines, Prasad briefly ordered the maker of a gene therapy for Duchenne's muscular dystrophy to halt shipments after two patient deaths. But that action triggered pushback from the families of boys with the fatal condition and libertarian supporters of increased access to experimental medicines. Prasad's decision to pause the therapy was criticized by The Wall Street Journal editorial board, former Republican Sen Rick Santorum and others. The FDA swiftly reversed its decision suspending the therapy's use. Loomer posted online that Prasad was 'a progressive leftist saboteur," noting his history of praising liberal independent Sen. Bernie Sanders. But Prasad has had the backing of FDA Commissioner Marty Makary and health secretary Robert F Kennedy Jr, who have both called for scrutinizing the use of COVID-19 vaccines. Under Prasad, the FDA restricted the approval of two new COVID-19 shots from vaccine makers Novavax and Moderna and set stricter testing requirements for future approvals. (AP) RD RD view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
The Hindu
2 hours ago
- The Hindu
Bengaluru firm in talks with A.P. govt. to launch helicopter emergency medical services in State
International Critical Care Air Transfer Team (ICATT), a Bengaluru-based air ambulance services company, initiated discussions with the Government of Andhra Pradesh (GoAP) for launching its integrated helicopter emergency medical services (HEMS) to fast-track trauma care services in the State. It conducted aero-medical drills in several Indian cities and is collaborating with the GoAP and leading tertiary hospitals to showcase HEMS, according to an official release. ICATT deploys flying ICUs — helicopters and aircraft equipped with advanced ICU infrastructure, surgical tools, and a trained aero-medical team. These airborne units are capable of delivering critical care at the site of trauma, particularly along highways, rural belts, and semi-urban areas, within the crucial golden hour, significantly improving the chances of survival for accident victims. Under HEMS, trauma victims and critically ill patients will be airlifted free of cost, ensuring timely access to lifesaving care. ICATT's air ambulance service, which is an India-specific adaptation of the U.K.'s HEMS model, has been successfully operating the government-funded PM Shri Air Ambulance Seva in Madhya Pradesh (M.P.). ICATT planned to replicate that model in other States by bringing together key departments including Fire Services, Police, and first-responder ambulance units to form a seamless emergency medical network. Prior to the M.P. contract, ICATT conducted aero-medical rescue operations in the deep jungles of the southern parts of Chhattisgarh and saved the lives of CRPF jawans who were fighting the Naxalites. ICATT founding directors Rahul Singh Sardar and Shalini Nalwad stated that HEMS represents a significant disruption in the emergency care landscape. In countries like the U.S.A., U.K., and across Europe, air ambulance teams were a standard part of trauma care. ICATT would bring to India the same global standard of care, where such services were not just desirable but essential. With access to advanced medical facilities still limited in many parts of the country, it (ICATT) believes that the introduction of HEMS would play a crucial role in reducing road accident fatalities and improving emergency response outcomes.
